Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 23 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-12-21 Ross Douglas T. Former CSO Grant or award +213,797 234,114
2022-12-16 Ross Douglas T. Former CSO. Returned to the company · Option to Purchase Common Stock −83,334 166,666
2022-12-16 Ross Douglas T. Former CSO. Returned to the company · Option to Purchase Common Stock −143,438 111,562
2022-12-16 Ross Douglas T. Former CSO. Returned to the company · Option to Purchase Common Stock −100,000 0
2022-12-16 Ross Douglas T. Former CSO. Returned to the company · Option to Purchase Common Stock −100,000 0
2022-12-01 Ross Douglas T. Former CSO. Returned to the company −150,000 20,317
2022-08-15 Ross Douglas T. Chief Scientific Officer Grant or award +150,000 170,317
2022-03-25 Ross Douglas T. Chief Scientific Officer Purchase +15,000 $1.40 $21K 20,317
2022-03-15 Ross Douglas T. Chief Scientific Officer Grant or award · Option to Purchase Common Stock +100,000 100,000
2022-03-15 Ross Douglas T. Chief Scientific Officer Grant or award · Option to Purchase Common Stock +100,000 100,000
2021-02-25 Ross Douglas T. Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +255,000 $5.34 $1.4M 255,000
2020-12-11 Ross Douglas T. CMO Grant or award +5,317 5,317

Page 1 of 1 · 12 trades